Who owns Gritstone Oncology Ord?
- Ticker: GRTS
- CUSIP Number: 39868t105
Tip: Access positions for across all investors
Analyze quarterly positions in Gritstone Oncology Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Gritstone Oncology Ord stock
Who bought or sold Gritstone Oncology Ord this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Redmile Group | 5.9M | $12M | -31% | Dec 2023 |
|
Vanguard Group | 4.4M | $9.0M | 9% | Dec 2023 |
|
Point72 Asset Management | 4.0M | $8.1M | -33% | Dec 2023 |
|
Versant Venture Management | 3.6M | $9.2M | 0% | Mar 2024 |
|
Frazier Life Sciences Management | 1.0M | $2.1M | -28% | Dec 2023 |
|
Susquehanna International | 852k | $2.2M | 198% | Mar 2024 |
|
Citadel Advisors | 361k | $736k | -3% | Dec 2023 |
|
Bank of New York Mellon | 317k | $814k | -3% | Mar 2024 |
|
Dimensional Fund Advisors | 287k | $737k | 101% | Mar 2024 |
|
Charles Schwab Investment Management | 267k | $687k | 0% | Mar 2024 |
|
Susquehanna Fundamental Investments | 248k | $636k | 1048% | Mar 2024 |
|
Jane Street | 201k | $410k | 100% | Dec 2023 |
|
UBS Group | 198k | $403k | -26% | Dec 2023 |
|
Bank of America Corporation | 188k | $383k | 320% | Dec 2023 |
|
Wells Fargo & Company | 184k | $473k | 321% | Mar 2024 |
|
Forum Financial Management | 153k | $394k | 70% | Mar 2024 |
|
Barclays | 142k | $289k | 286% | Dec 2023 |
|
Goldman Sachs Group | 137k | $280k | -26% | Dec 2023 |
|
Rhumbline Advisers | 127k | $328k | 3% | Mar 2024 |
|
Artia Global Partners | 95k | $194k | 0% | Dec 2023 |
|
T. Rowe Price Associates | 84k | $171k | 4% | Dec 2023 |
|
CornerCap Investment Counsel | 77k | $197k | 0% | Mar 2024 |
|
Jpmorgan Chase & Co | 63k | $129k | -15% | Dec 2023 |
|
Two Sigma Investments | 50k | $103k | 100% | Dec 2023 |
|
MetLife Investment Advisors | 47k | $95k | 0% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 46k | $119k | 85% | Mar 2024 |
|
Royal Bank of Canada | 44k | $90k | 25% | Dec 2023 |
|
American International | 44k | $89k | 0% | Dec 2023 |
|
Twin Peaks Wealth Advisors | 40k | $104k | 0% | Mar 2024 |
|
HighTower Advisors | 35k | $91k | 33% | Mar 2024 |
|
Klingman & Associates | 35k | $89k | 100% | Mar 2024 |
|
Advisor Group Holdings | 33k | $67k | 211% | Dec 2023 |
|
SkyOak Wealt | 31k | $81k | -14% | Mar 2024 |
|
Stifel Financial | 31k | $63k | -55% | Dec 2023 |
|
Captrust Financial Advisors | 29k | $59k | -79% | Dec 2023 |
|
Creative Planning | 25k | $51k | 0% | Dec 2023 |
|
Millennium Management | 24k | $49k | -98% | Dec 2023 |
|
SG Americas Securities | 24k | $61k | -39% | Mar 2024 |
|
Squarepoint Ops | 23k | $47k | -56% | Dec 2023 |
|
Raymond James Financial Services Advisors | 22k | $57k | 0% | Mar 2024 |
|
Houlihan Financial Resource Group | 20k | $51k | 0% | Mar 2024 |
|
New York State Common Retirement Fund | 19k | $50k | -53% | Mar 2024 |
|
Alliancebernstein | 18k | $37k | 0% | Dec 2023 |
|
Honkamp Krueger Financial Services | 18k | $46k | 100% | Mar 2024 |
|
Citigroup | 17k | $44k | 33% | Mar 2024 |
|
ProShare Advisors | 16k | $42k | -7% | Mar 2024 |
|
Wexford Capital | 13k | $26k | 100% | Dec 2023 |
|
Valeo Financial Advisors | 12k | $9.8k | 0% | Mar 2024 |
|
Fairhaven Wealth Management | 12k | $31k | 0% | Mar 2024 |
|
Walleye Trading Advisors | 12k | $25k | 100% | Dec 2023 |
|
Victory Capital Management | 12k | $30k | 0% | Mar 2024 |
|
Dynamic Technology Lab Private | 12k | $24k | 100% | Dec 2023 |
|
Principal Financial Group | 10k | $27k | -8% | Mar 2024 |
|
Summit Investment Advisors | 7.2k | $15k | 0% | Dec 2023 |
|
Legal & General Group | 7.1k | $15k | -16% | Dec 2023 |
|
FinTrust Capital Advisors | 4.0k | $10k | 0% | Mar 2024 |
|
Amalgamated Bank | 3.0k | $8.0k | -61% | Mar 2024 |
|
Metropolitan Life Insurance Company | 1.0k | $2.1k | -79% | Dec 2023 |
|
EverSource Wealth Advisors | 649.00 | $1.3k | 0% | Dec 2023 |
|
Russell Investments | 174.00 | $447.006000 | 0% | Mar 2024 |
|
NISA Investment Advisors | 114.00 | $293.002800 | 21% | Mar 2024 |
|
Hanson McClain Advisors | 100.00 | $257.000000 | 0% | Mar 2024 |
|
Pnc Financial Services | 57.00 | $145.999800 | 0% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 24.00 | $61.000800 | 100% | Mar 2024 |
|
Farther Finance Advisors | 24.00 | $49.000800 | 100% | Dec 2023 |
|
FNY Investment Advisers | 8.00 | $0 | 100% | Mar 2024 |
|
Cubist Systematic Strategies | 6.00 | $12.000000 | 0% | Dec 2023 |
|
Who sold out of Gritstone Oncology Ord?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Avidity Partners Management | Sep 2023 | 2.7M | $4.7M |
Balyasny Asset Management | Sep 2023 | 2.1M | $3.6M |
PanAgora Asset Management | Dec 2023 | 201k | $411k |
Moore Capital Management | Sep 2023 | 100k | $172k |
Deutsche Bank Aktiengesellschaft | Sep 2023 | 50k | $86k |
Worth Venture Partners | Sep 2023 | 44k | $75k |
Simplex Trading | Dec 2023 | 23k | $47k |
Florida State Board of Administration | Dec 2023 | 23k | $47k |
Diversified Trust Company | Dec 2023 | 12k | $23k |
Lazard Asset Management | Sep 2023 | 5.9k | $0 |
Advisory Services Network | Dec 2023 | 680.00 | $1.4k |
Zurcher Kantonalbank | Dec 2023 | 480.00 | $979.008000 |